The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -585,525 |
| Depreciation and amortization | 3,248 |
| Stock-based compensation | 19,082 |
| Non-cashlease expense | 1,853 |
| Accretion of discount on marketable securities | 480 |
| Transaction costs allocated to common stock warrants | 3,223 |
| Change in fair value of second lien loans | 24,387 |
| Change in fair value of simple agreements for future equity | 190,075 |
| Change in fair value of redeemable convertible preferred stock warrant liabilities-Redeemable Convertible Preferred Stock Warrants | 7,272 |
| Change in fair value of redeemable convertible preferred stock warrant liabilities-Common Stock Warrants | 35,018 |
| Loss on issuance of equity instruments | -210,722 |
| Non-cashinterest expense | 795 |
| Loss on disposal of property and equipment | -265 |
| Accounts receivable | -401 |
| Prepaid expenses and other current assets | 2,180 |
| Other assets | 105 |
| Accounts payable | -717 |
| Accrued expenses and other current liabilities | -407 |
| Operating lease liabilities | -1,861 |
| Other liabilities | 492 |
| Net cash used in operating activities | -94,442 |
| Proceeds from maturities of marketable securities | 0 |
| Purchases of marketable securities | 69,406 |
| Purchases of property and equipment | 22,026 |
| Payment of deposits | 0 |
| Net cash (used in) provided by investing activities | -91,432 |
| Proceeds from the issuance of debt, net of issuance costs | 29,662 |
| Repayment of debt | 33,381 |
| Proceeds from issuance of second lien loans | 43,865 |
| Proceeds from issuance of simple agreements for future equity | 23,660 |
| Proceeds from issuance of series a cumulative redeemable convertible preferred stock | 145,000 |
| Proceeds from the reverse recapitalization, net of transaction costs | 26,239 |
| Proceeds from exercise of stock options | 1,422 |
| Proceeds from exercise of common stock warrants | 77 |
| Payments for deferred offering costs | 16,618 |
| Net cash provided by financing activities | 219,926 |
| Net change in cash and cash equivalents and restricted cash | 34,052 |
| Cash and cash equivalents and restricted cash at beginning of period | 18,159 |
| Cash and cash equivalents and restricted cash at end of period | 52,211 |
Kodiak AI, Inc. (KDK)
Kodiak AI, Inc. (KDK)